This role focuses on the medical evidence strategy for Pfizer's RSV adult vaccine program.
Base: $230,900.00 to $384,800.00; Bonus/Equity: 25.0% of base salary; Benefits: Comprehensive health benefits and 401(k) plan
Must-have
Nice-to-have
Must have US work authorization